Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 441.90
+17.50 (4.12%)
May 6, 2026, 3:30 PM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 83 billion as of May 6, 2026. Its market cap has increased by 46.02% in one year.
Market Cap
83.00B
Enterprise Value
88.73B
Revenue
14.33B
Ranking
n/a
PE Ratio
55.32
Stock Price
441.90
Market Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 83.00B, an increase of 183,956.96%. That is a compound annual growth rate of 32.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 86.47B | 37.64% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 188.24B |
| Cohance Lifesciences | 173.74B |
| Alembic Pharmaceuticals | 151.22B |
| Alivus Life Sciences | 132.14B |
| Strides Pharma Science | 96.97B |
| Akums Drugs and Pharmaceuticals | 84.63B |
| Sudeep Pharma | 77.52B |
| Aarti Pharmalabs | 69.58B |